GLP-1 receptor agonists: a magic bullet for obesity?

被引:0
|
作者
不详
机构
来源
关键词
D O I
10.1016/j.lanwpc.2024.101233
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Obesity and prediabetes. Treatment using GLP-1 receptor agonists
    Ritzel, R. A.
    DIABETOLOGE, 2017, 13 (07): : 482 - 486
  • [22] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [23] GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity
    Romariz, Livia
    Araujo, Beatriz
    Barbosa, Lucas M.
    Jain, Riddhi
    Porto Silva Janovsky, Carolina C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 132 : 153 - 155
  • [24] GLP-1 receptor agonists and suicidality
    Ueda, Peter
    Pasternak, Bjorn
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [25] GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach
    Wang, Jing-Yue
    Wang, Quan-Wei
    Yang, Xin-Yu
    Yang, Wei
    Li, Dong-Rui
    Jin, Jing-Yu
    Zhang, Hui-Cong
    Zhang, Xian-Feng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [26] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [27] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [28] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [29] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [30] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570